FDA vaccine advisers are meeting to consider Moderna Covid-19 vaccine boosters

Vaccine advisers to the US Food and Drug Administration are meeting Thursday to discuss whether to authorize boosters of Moderna's coronavirus vaccine for some adults.

It's the first portion of a two-day Vaccines and Related Biological Products Advisory Committee meeting that will also include a vote on boosters for the Johnson & Johnson vaccine and a presentation on mix-and-match vaccines. Thursday's agenda focuses on Moderna boosters, and includes a presentation by Moderna, and another by the FDA, which will provide its assessment of Moderna's booster data.